Enhancement of Neoangiogenesis and Follicle Survival by Sphingosine-1-Phosphate in Human Ovarian Tissue Xenotransplants
Author Information
Author(s): Soleimani Reza, Heytens Elke, Oktay Kutluk
Primary Institution: New York Medical College
Hypothesis
Can sphingosine-1-phosphate and its agonists improve neoangiogenesis and primordial follicle survival during human ovarian cortical tissue transplantation?
Conclusion
Sphingosine-1-phosphate promotes neoangiogenesis in ovarian transplants and reduces ischemic reperfusion injury, enhancing follicle survival.
Supporting Evidence
- Sphingosine-1-phosphate treatment increased vascular density in ovarian transplants significantly.
- Sphingosine-1-phosphate accelerated the angiogenic process compared to vehicle-treated controls.
- Sphingosine-1-phosphate treatment resulted in a significantly lower percentage of apoptotic follicles.
Takeaway
This study shows that a substance called sphingosine-1-phosphate helps new blood vessels grow in transplanted ovaries, which helps the eggs survive better.
Methodology
Human ovarian tissue xenografts in severe-combined-immunodeficient mice were treated with sphingosine-1-phosphate or its analogs for 1–10 days to assess vascular density and follicle survival.
Limitations
The study was conducted in a xenograft model, which may not fully replicate human physiological conditions.
Participant Demographics
Ovarian tissue was obtained from consenting female patients aged 2 to 37 undergoing ovarian tissue freezing before chemotherapy.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website